P.A. Leeson

647 citations
30 papers · 154 indexed · h-index 8
Topics
Synthesis and biological activity (2 papers)Chronic Lymphocytic Leukemia Research (2 papers)Vitamin D Research Studies (2 papers)
Partner nations
United Kingdom

In The Last Decade

P.A. Leeson

28 papers receiving 133 citations

Peers

P.A. Leeson
Comparison fields: 5 of 66
  • Organic Chemistry 49
  • Molecular Biology 45
  • Surgery 29
  • Pharmacology 20
  • Oncology 20
Replace Meredith A. Allen with:
Meredith A. Allen United States
Jakal Amin United States
Naoya Matsumura Japan
Rolf Grosser Germany
Benjamin Noll Australia
Keiichi Kuwano Japan
Thomas H. Williams United States
Steven W. Louie United States
Tetsuhiro Yamada Japan
B. Wirz Switzerland
P.A. Leeson relative to Meredith A. Allen United States Meredith A. Allen's profile →
Citations per field
00.5×1.5×
Meredith A. Allen · 1×
Citations per year

Countries citing papers authored by P.A. Leeson

Since Specialization
Citations

This map shows the geographic impact of P.A. Leeson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.A. Leeson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.A. Leeson more than expected).

Fields of papers citing papers by P.A. Leeson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.A. Leeson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.A. Leeson. The network helps show where P.A. Leeson may publish in the future.

Co-authorship network of co-authors of P.A. Leeson

This figure shows the co-authorship network connecting the top 25 collaborators of P.A. Leeson. A scholar is included among the top collaborators of P.A. Leeson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P.A. Leeson. P.A. Leeson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 14
3 2
4
NXY-059: Treatment of ischemic stroke, free radical scavenger
1
5 2
6 5
7 10
8 4
9 4
10 4
11 6
12 7
13 3
14 1
15 1
16 1
17 12
18 0
19 12
20 4

About P.A. Leeson

P.A. Leeson is a scholar working on Complementary and Manual Therapy, Genetics and Nephrology, having authored 30 papers that have together received 154 indexed citations. Recurring topics across this work include Synthesis and biological activity (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Vitamin D Research Studies (2 papers). The work is most often cited by research in Organic Chemistry (49 citations), Pharmacology (20 citations) and Otorhinolaryngology (5 citations). P.A. Leeson has collaborated with scholars based in United Kingdom. Frequent co-authors include J. Castañer, Paul Fourman, M. Bayés, Jean‐Sébastien Silvestre, X Rabasseda, J. Castañer, Martín Cullell-Young, Luis H. Martín Arias, L.A. Sorbera and Mariana del Fresno. Their work appears in journals such as The Lancet, The Journal of Laryngology & Otology and Drugs of the Future.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026